High CD44 expression is not a prognosis marker in patients with high-risk neuroblastoma 1 Mar, 2020 Nom de la revue EBioMedicine Caroline Louis-Brennetot, Olivier Delattre, Isabelle Janoueix-Lerosey DOI 10.1016/j.ebiom.2020.102702 Teams / Core Facilities Diversity and Plasticity of Chilhood Tumors (DePiCT) OLIVIER DELATTRE